Latest Forum Topics /
Valuetronics
Last:0.99
+0.005
|
|
|
Valuetronic
|
|||||
|
baicho
Veteran |
09-Aug-2026 17:21
|
||||
|
x 0
x 0 Alert Admin |
REPOSTED FOR THE BENEFIT OF NEW READERS
 
INVESTMENT ANALYSIS &bull 15 MAY 2026 &bull BY Cedric
 
Beyond the 2,973% Surge: Why ISDN&rsquo s 1Q 2026 Results Are the Real Deal
 
For those who knows me, I' m an almost decade long ISDN investor. Been attending every briefing, AGM, knowing the company. Today' s 1Q sheds new light on its future. I will be doing a deep dive into the nuances of industrial recovery, operating leverage, and the path to $0.96 (CGSI Target Price)
 
If you only looked at the headline numbers for ISDN Holdings&rsquo 1Q 2026 results, you&rsquo d be forgiven for thinking there was a typo. A 2,973% increase in net profit is the kind of figure that usually screams " accounting anomaly" or " one-off gain." But for those of us who have been tracking this company through the lean years of 2023 and 2024, these results aren' t just a statistical fluke&mdash they are the first loud signal that the engine is finally back in gear.
 
Let&rsquo s be real for a moment: the percentage is high because 1Q 2025 was a painfully low base. However, moving past the shock value of that growth, the underlying health of the business tells a much more compelling story. Revenue is up 24.2% year-on-year to S$113.7 million. More importantly, the net profit margin has expanded from a razor-thin 0.7% to a healthy 4.7%.
 
1) The Seasonality Myth
In the world of industrial automation, the first quarter is historically the " quiet" one. Between the Lunar New Year factory shutdowns in China and the post-holiday lull in production, ISDN usually records its lowest numbers of the year in 1Q. Historically, this period accounts for barely 20% of annual revenue. This is why the 1Q 2026 performance is so significant. If the company is already hitting S$113.7 million in revenue during its " slowest/shortest" period, what happens when we hit the peak industrial cycles of 3Q? We are looking at a trajectory that doesn' t just meet expectations&mdash it likely shatters them.
 
2) Operating Leverage: The Lean Machine
The most satisfying nuance in this press release isn' t the sales growth it&rsquo s the cost control. For several years, ISDN was in a " gestation" phase&mdash hiring specialized engineers, expanding into new markets like Vietnam, and building out its hydropower infrastructure. In 1Q26, we finally saw " Operating Leverage" in action. While revenue grew by 24%, operating expenses only grew by 12%. This means the heavy lifting of building the platform is done, and every new dollar of sales is now dropping much more efficiently to the bottom line. This is exactly what you want to see in a growth-to-value transition.
 
" The shift isn' t just about moving parts anymore. ISDN has successfully pivoted into the AI and Robotics supply chain, servicing the very data centres and automated factories that are defining this decade."
 
3) The Hydropower Hedge
One detail that might have slipped past casual readers was the performance of the Renewable Energy pillar. Existing plants actually saw a dip in generation due to weather volatility, which is a once in a blue moon abnormally. However, the company offset this with S$4.9 million in construction income from its new plants, Lau Biang 2 and 3.
 
As an investor, I view this as a temporary weather-related " hiccup" that masks a long-term goldmine. Once these two plants come fully online later this year, they will provide a high-margin, recurring revenue stream that is completely decoupled from the volatile semiconductor cycle. It&rsquo s the " safety net" the company has been building for years.
 
4) Sanity Checking the $0.96 Target
CGS International (CGSI) recently put out a target price of S$0.96. At the time, it felt ambitious. But looking at these numbers, the math starts to look conservative. CGSI projected a full-year net profit of roughly S$15.3 million. ISDN has already banked 24% of that in its historically weakest quarter.
 
If the company follows its usual seasonal ramp-up, we could see full-year profits crossing the S$20 million mark. At that level, an EPS of 4.5 to 5.0 cents is well
within reach. Even at a modest 18x P/E&mdash hardly aggressive for a company with a foot in both AI and Green Energy&mdash that S$0.90+ range is fundamentally supported.
 
Final Thoughts
Is it a smooth ride? Rarely. Industrial stocks are always sensitive to global macro
shifts. But the " nuances" in this 1Q release suggest that ISDN is no longer the entity it was during the 2024 inventory digestion phase. It is leaner, more diversified, and clearly benefitting from the AI-driven retooling of global factories. The years of investing in hiring talented manpower and businesses over the downturn have helped the company increase their market share during the upturn. We are reaping the rewards from a long term focused management.
 
For those of us holding for the long term, this quarter was the proof of concept we
needed. The " turnaround" is over the " expansion" has begun.
 
© 2026 Investment Insights. This article reflects the personal analysis of an independent investor and does not constitute financial advice.
 
DUE DILIGENCE WARRANTED.
 
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
03-Aug-2026 09:09
|
||||
|
x 0
x 0 Alert Admin |
Lion Global Investors accumulates shares in Valuetronics and iX Biopharma [SINGAPORE] Over the five sessions, more than 50 director interests and substantial shareholdings were filed for close to 30 primary-listed stocks. Directors or chief executives reported four acquisitions and no disposals, while substantial shareholders recorded five acquisitions and one disposal. This included CEO or director acquisitions filed for Alpha Integrated Reit : M1GU 0%, Aztech Global : 8AZ -1.47%, iFast Corp : AIY +2.13% and Toku : TKU +1.59%. On Jul 28, iWow Technology : NXR -2.13% completed its S$15 million placement through the issuance of 66.7 million new shares at S$0.225 per share. The placement attracted institutional and strategic investors including fund managers under Singapore&rsquo s Equity Market Development Programme, alongside investors such as Lion Global Investors, UOB Asset Management, Tokio Marine Life Insurance Singapore and Value Partners Hong Kong. Share buybacks In addition, the five sessions saw a dozen primary-listed companies conduct buybacks with a total consideration of S$26.7 million, a similar pace to the previous week. Aztech Global executive chairman raises stake On Jul 29, Aztech Global executive chairman and chief executive officer Michael Mun acquired 100,000 shares at an average purchase price of S$0.715 per share. Following the market purchase, Mun&rsquo s total interest in the company increased to 542.8 million shares. This is equivalent to 70.3 per cent of Aztech Global&rsquo s issued share capital. The share purchase came a day after Aztech Global reported first-half 2026 net profit of S$9.4 million on revenue of S$151.4 million and declared an interim dividend of S$0.005 per share. The group also highlighted that it secured 13 new project orders and added four new customers during the first half as part of its customer and revenue diversification effort. iFast chairman and group CEO increases stake On Jul 29, Lim Chung Chun, chairman and group chief executive officer of iFast, bought 36,200 shares on the market for S$316,326, representing an average purchase price of S$8.74 per share. Following the acquisition, his total interest in the group increased to 60.1 million shares, equivalent to 19.6 per cent of the company&rsquo s issued shares. The share purchase followed iFast&rsquo s release of its second-quarter results on Jul 24, which reported a 35 per cent year-on-year increase in net profit to S$29.9 million and a 32.8 per cent increase in assets under administration to a record S$36.1 billion. The group also raised its FY2026 dividend guidance to at least S$0.12 per share and declared a second interim dividend of S$0.03 per share. Lion Global Investors&rsquo Valuetronics purchase On Jul 24, Lion Global Investors acquired 180,600 Valuetronics Holdings : BN2 +2.88% shares at an average price of S$1.12 per share. The purchase increased the asset manager&rsquo s deemed interest from 19.7 million shares (4.83 per cent) to 19.88 million shares (4.88 per cent). The transaction also lifted OCBC&rsquo s deemed interest from 4.98 per cent to 5.02 per cent, or 20.49 million shares, resulting in the bank emerging as a substantial shareholder. This follows a series of stake increases by Amova Asset Management Asia, which emerged as a substantial shareholder in March after its managed portfolios crossed the 5 per cent threshold. The fund manager subsequently increased its interest to 6.11 per cent in April and 7.15 per cent in May, equivalent to 29.31 million shares. At Valuetronics&rsquo annual general meeting on Jul 27, management outlined plans to return about HK$300 million (US$38.3 million) of surplus cash to shareholders over FY2027 and FY2028 through a combination of special dividends and share buybacks. Management indicated that HK$66 million has been earmarked for the FY2026 special dividend and that not less than HK$80 million will be deployed under the initial share buyback programme. The balance of the HK$300 million capital return programme will be available for further special dividends and/or share buybacks over FY2027 and FY2028. The programme reflects the board&rsquo s assessment of the group&rsquo s strong financial position and cash flow generation, with management highlighting a disciplined capital allocation framework that balances shareholder returns with working capital, capital expenditure, financial resilience and strategic growth requirements. The company also raised its ordinary dividend payout target to 50 to 70 per cent of net profit, up from the previous 30 to 50 per cent range. Including the proposed final and special dividends for FY2026, total dividends amount to HK$0.38 per share, representing a 41 per cent increase from the HK$0.27 per share paid for FY2025. Management highlighted that despite a 4 per cent decline in FY2026 revenue to HK$1.7 billion, gross profit increased 6.3 per cent to HK$312.1 million and gross margin expanded to 18.8 per cent from 17 per cent. Excluding the impact of the Trio AI investment, adjusted profit before income tax improved to HK$179.1 million from HK$174.7 million in FY2025, reflecting resilience in the group&rsquo s core electronics manufacturing services business. Revenue mix also continued to shift towards the communication electronics segment, which accounted for 87.1 per cent of group revenue in FY2026 compared with 78.8 per cent in FY2025. Lion Global Investors&rsquo iX Biopharma purchase On Jul 22, Lion Global Investors acquired 3.71 million iX Biopharma : 42C 0% shares. The purchase increased the asset manager&rsquo s deemed interest from 49.54 million shares (4.54 per cent) to 53.25 million shares (4.87 per cent). The transaction also lifted OCBC&rsquo s deemed interest from 4.71 per cent to 5.04 per cent, or 55.15 million shares, resulting in the bank emerging as a substantial shareholder. The stake increase follows a series of strategic developments for iX Biopharma. In February, the speciality pharmaceutical company completed a placement of 75.8 million new shares, raising gross proceeds of at least S$6 million. Cash and cash equivalents increased to S$15.9 million as at Mar 31, 2026, while net assets improved to S$17 million from S$400,000 at the end of FY2025. Working capital also improved to a surplus of S$11.3 million from a deficit of S$4.8 million. At its July corporate briefing, management highlighted continued progress for Wafermine, its proprietary sublingual ketamine wafer being developed for acute moderate-to-severe pain. The programme has completed its end-of-Phase II meeting with the US Food and Drugs Administration and is progressing towards Phase III development. Management disclosed that operational medical systems is expected to provide about US$34.3 million of funding for Phase III studies, while iX Biopharma retains product rights and sponsorship. In February, the company also announced a US$41 million US Department of Defense contract to further develop Wafermine for potential battlefield deployment under an emergency use authorisation pathway. The company has approved the relocation of key manufacturing equipment from Australia to a US facility in Nevada. Management noted that the move supports Buy American Act requirements, accelerates manufacturing readiness for Wafermine, and provides access to additional pharmaceutical manufacturing opportunities in the US market. iX Biopharma will retain ownership of the equipment and underlying intellectual property. For the nine months ended Mar 31, 2026, revenue declined 14 per cent year on year to S$4.8 million. However, gross profit increased 7 per cent to S$1.4 million and gross margin expanded to 30 per cent from 24 per cent, reflecting an improved product mix. Net loss narrowed to S$3 million from S$8.4 million a year earlier, while adjusted Ebitda loss improved to S$1.7 million from S$1.9 million. Management continues to position iX Biopharma around its WaferiX drug-delivery platform, which supports more than 40 pharmaceutical development programmes spanning pain management, peptides, hormones and metabolic health. Recent developments include a strengthened balance sheet, Phase III funding support for Wafermine, progress towards US manufacturing capability and a Department of Defense-backed development programme. Aedge: Funding property expansion & recurring income growth Aedge Group : XVG 0% has proposed a placement of 16.67 million new shares at S$0.21 per share to raise gross proceeds of some S$3.5 million. The new shares will account for about 9.3 per cent of the enlarged share capital. The company&rsquo s previous placement was in May 2025, when it issued 1.95 million new shares at S$0.26 per share to raise gross proceeds of S$507,000. Aedge intends to allocate about half of net proceeds towards expanding its investment properties division and the remaining 50 per cent towards working capital. The company also cited broadening its shareholder base and potentially improving trading liquidity as objectives of the placement. The placement follows the group&rsquo s continued expansion of its industrial property portfolio, including the June 2026 acquisition of 219 Kallang Bahru, its third industrial building acquisition. Aedge&rsquo s H1 FY2026 (ended Dec 31) saw revenue increase 30.2 per cent year on year to S$17.3 million, while gross profit more than doubled to S$3.5 million and net profit reached S$1.1 million, compared with a loss of S$500,000 a year earlier. Management was cautiously optimistic on H2 FY2026, citing recent contract wins across its engineering, transportation and security businesses. Additionally, the expected operational commencement of a second worker dormitory will more than double the group&rsquo s bed capacity and further increase recurring rental income. As at Dec 31, Catalist-listed Aedge reported investment properties with a carrying value of S$19.4 million and an assessed fair value of about S$26 million. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
seanpent
Supreme |
21-Jul-2026 12:43
|
||||
|
x 0
x 0 Alert Admin |
more than sufficient rest ... time to launch rocket | ||||
| Useful To Me Not Useful To Me | |||||
|
Delvyss
Elite |
01-Jul-2026 09:49
|
||||
|
x 0
x 0 Alert Admin |
Daily Share Buy-Back Notices https://www.valuetronics.com.hk/ir/announce.html |
||||
| Useful To Me Not Useful To Me | |||||
|
Delvyss
Elite |
30-Jun-2026 13:19
|
||||
|
x 0
x 0 Alert Admin |
This one also moving out of its consolidation phase.  May probably see another big move soon. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
seanpent
Supreme |
16-Jun-2026 11:05
|
||||
|
x 0
x 0 Alert Admin |
collection mode 
|
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
15-Jun-2026 15:11
|
||||
|
x 0
x 0 Alert Admin |
I would like to see what their target prices for other tech companies are if they have $1.88 for this! | ||||
| Useful To Me Not Useful To Me | |||||
|
Fiat500
Veteran |
14-Jun-2026 20:29
|
||||
|
x 0
x 0 Alert Admin |
I doubt $1.88...To reach $1.50 also a bit tough already..
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
seanpent
Supreme |
11-Jun-2026 16:21
|
||||
|
x 0
x 0 Alert Admin |
$1.88 ?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Delvyss
Elite |
11-Jun-2026 16:10
|
||||
|
x 0
x 0 Alert Admin |
Looking forward to the share buyback, which hopefully will give even more strength to gthe share price. | ||||
| Useful To Me Not Useful To Me | |||||
|
Delvyss
Elite |
09-Jun-2026 10:37
|
||||
|
x 0
x 0 Alert Admin |
Recent Insider Transactionshttps://simplywall.st/stocks/sg/tech/sgx-bn2/valuetronics-holdings-shares/ownership |
||||
| Useful To Me Not Useful To Me | |||||
|
Delvyss
Elite |
08-Jun-2026 13:21
|
||||
|
x 0
x 0 Alert Admin |
Valuetronics Holdings Maintains ACCUMULATE Rating Despite Earnings Decline, Target Price Raised to S$1.29https://www.poems.com.sg/market-journal/valuetronics-accumulate-rating-earnings-decline-target-raised/ |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Delvyss
Elite |
05-Jun-2026 15:13
|
||||
|
x 0
x 0 Alert Admin |
Valuetronics FY2026 Results: Financial Performance, Dividend Policy Raised to 50-70% Payout, and Special Dividends Announcedhttps://www.minichart.com.sg/2026/05/28/valuetronics-fy2026-results-financial-performance-dividend-policy-raised-to-50-70-payout-and-special-dividends-announced/#google_vignette |
||||
| Useful To Me Not Useful To Me | |||||
|
seanpent
Supreme |
04-Jun-2026 13:43
|
||||
|
x 0
x 0 Alert Admin |
Did Amova follow thru with more purchase, or short squeezing ?
|
||||
| Useful To Me Not Useful To Me | |||||
|
seanpent
Supreme |
04-Jun-2026 11:32
|
||||
|
x 0
x 0 Alert Admin |
No wonder.  An astute investor, with deep expertise across Asian and global markets. 
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
04-Jun-2026 10:24
|
||||
|
x 0
x 0 Alert Admin |
Fund manager Amova raises stake in Valuetronics to above 7%
Valuetronics (SGX:BN2) announced that its substantial shareholder, Amova Asset Management, has acquired 1,030,100 shares back on May 28.
In the SGX filing dated June 3, the shares were purchased for a total consideration of $1,200,375.53, which excludes brokerage and stamp duties. This translates to an average price of around $1.16.
With this latest transaction, this brings Amova&rsquo s stake in Valuetronics from the previous 6.9% to 7.15%.
Back on May 28, Valuetronics has reported lower earnings for FY2026 due to an impairment of an underperforming associate.
Despite the lower earnings, John Cheong and Heidi Mo of UOB Kay Hian have nearly doubled their target price for Valuetronics from $1.03 to $1.88, with an eye on the manufacturer' s better earnings visibility, shift towards higher margin products, plus a clear capital return plan.
Shares in Valuetronics closed 2 cents lower or 1.8% down at $1.09 on June 3. On a year-to-date basis, Valuetronics&rsquo share price witnessed a gain of 27.49%.
|
||||
| Useful To Me Not Useful To Me | |||||
|
hongonn
Member |
02-Jun-2026 14:46
|
||||
|
x 0
x 0 Alert Admin |
Is that mean there are hkd 130m of GPUs not yet written off during the last exercise and hoping to recoup the hkd 130m of GPUs by year end?   |
||||
| Useful To Me Not Useful To Me | |||||
|
PiRPiR
Master |
02-Jun-2026 12:25
|
||||
|
x 0
x 0 Alert Admin |
https://app.poems.com.sg/kSPr/cd2e8cnl | ||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
31-May-2026 19:08
|
||||
|
x 0
x 1 Alert Admin |
I don' t see much upside to this share price from here in the long term. Up to a year ago it was undervalued but was a value trap due to its inefficient use of capital. It then boosted interest in its stock due to its AI play with the share price increasing to what it should have been had it been capital efficient. Now it turns out that its AI play is a busted flush but concurrently announces a more efficient capital usage. So in a roundabout way the share price is now in the right place. But it remains a relatively unexciting business with limited AI exposure. | ||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
30-May-2026 13:38
|
||||
|
x 1
x 0 Alert Admin |
UOBKH raises target price for Valuetronics to $1.88 on earnings and capital returns visibility Valuetronics Holdings has reported lower earnings for its FY2026 because of an impairment of an underperforming associate. However, John Cheong and Heidi Mo of UOB Kay Hian have nearly doubled their target price from $1.03 to $1.88, with an eye on the manufacturer' s better earnings visibility, shift towards higher margin products, plus a clear capital return plan. For the year ended March, Valuetronics recorded revenue of HK$1.65 billion, down 4%, in line with what they were expecting. The company reported earnings of HK$111 million, down 33.1%, weighed down by a HK$48.4 million impairment made for Trio AI. If excluded, the bottom line would have been HK$160 million, down 4%. The impairment of Trio AI was made because of weaker-than-expected demand. Valuetronics is weighing options such as recovering value from the GPUs by redeploying the hardware, or sell to other companies and potentially recoup around HK$130 million by end of 2026, according to Cheong and Mo. That aside, the analysts believe that with a more favourable product mix, Valuetronics can expect its gross margin, which was at 18.8% in FY2026, to remain at a " healthy" level going forward. From their perspective, what is also interesting about the company is its capital management. Even with the lower earnings, the company plans to pay final and special dividends that will bring its full-year total to 38 HK cents, up from 27 KHK cents in the preceding year. Backed by its strong cash position of HK$1.2 billion, the company has launched a plan to return HK$300 million to shareholders over two years. For one, it will improve its dividend payout policy from 30 to 50%, to 50 to 70%. In the current FY2027, it is allocating around HK$66 million in special dividends and not less than HK$80 million in share buybacks. The remaining HK$154 million will be used for the following FY2028. Meanwhile, Cheong and Mo, citing improving earnings visibility and a positive shift to higher margin products, have applied a higher valuation multiple of 19x ex-cash FY2028 earnings, up from 13x previously, leading to a higher target price of $1.88, up from $1.03 previously. The analysts note that Valuetronics is now trading at just 10x FY2028 ex-cash earnings and offers an attractive FY2028 dividend yield of about 6%. " We believe valuations remain undemanding, given Valuetronics&rsquo s defensive earnings profile and strong cash generation," state Cheong and Mo. Valuetronics shares, as at 2.33 pm, changed hands at $1.14. |
||||
| Useful To Me Not Useful To Me | |||||

